-
Lula, Bolsonaro strike calmer tone in final Brazil election debate
-
Marc Marquez wins Australian sprint as Martin crashes out
-
'How is it possible?': Students protest Indonesian haze
-
North Korea's Kim calls for training world's 'strongest' military
-
Israel launches major West Bank operation after soldiers killed
-
Brewers edge Rays to capture World Series opener
-
Typhoon Champi knocks out power to thousands in Taiwan
-
France to deploy 70,000 police for fresh weekend protests
-
As Israeli election nears, campaign turns ugly
-
Tatum delivers as Celtics down winless Knicks
-
Oscar hopeful 'La Bola Negra' offers lessons about communicating, directors say
-
Romantasy fans ready for sleepless night as 'Court of Thorns and Roses' returns
-
Trapped: Soaring fuel costs hurt Maine lobster industry before midterms
-
De Goede hat-trick as Canada defeat England again
-
Marc Marquez beats brother Alex to Australian MotoGP pole
-
Rubio urges Cubans to work with CIA, but warns: be discreet
-
Ebola vaccine trial begins in DR Congo
-
Leclerc tops times for Ferrari in practice for US Grand Prix
-
Travelling man Wade equals Prem try record
-
Lula, Bolsonaro lock horns in final debate before Brazil vote
-
Rescuers search for seven people in Nairobi building collapse
-
Poulter and Hatton leave LIV Golf
-
Sacha Baron Cohen revives the 'problematic dinosaur' Ali G in new film
-
Blakely vaults out of the shadow of Biles for all-around world title
-
New race in Barcelona tops 17-event '27 IndyCar season
-
Oil tops $116 with stocks mixed on earnings, AI
-
Neymar backs Flavio Bolsonaro in Brazil election
-
Trump orders lawsuit to block Alaska Senate result if Republicans lose
-
Melania Trump says she brokered truce in war-torn Ukrainian city
-
Ebola patient in Nigeria is Swiss, had not visited DR Congo: Bern
-
Leclerc tops times for Ferrari in opening practice for US Grand Prix
-
Messi receives top Spanish award from heir to throne
-
Bayern Munich coach Kompany in hospital after collapsing
-
Macron condemns 'racist terrorist attack' after deadly shooting near Paris
-
Signs point to renewed major US military ops against Iran
-
Shiffrin sidesteps slalom in 'exploration' season
-
European, Mideast foreign ministers push peace and diplomacy at Istanbul talks
-
Bayern Munich coach Kompany in hospital after collapsing: club
-
Ex-All Black centre Williams undergoes 'miracle' heart surgery
-
Alonso sees Courtois similarities in Chelsea's Penders
-
Netanyahu launches major West Bank operation after Israeli soldiers killed
-
Melania Trump announces truce in Ukrainian city 'on brink of disaster'
-
AFP photographer captures striking images from West Bank attack
-
Saka to be carefully managed after latest injury setback, says Arteta
-
Oil hits $116 with stocks mixed on earnings, AI
-
Goodell says NFL's France debut 'just the beginning'
-
De Zerbi says Tottenham's dire record at Chelsea 'more motivation'
-
Singapore widens haze probe to local firms linked to Indonesian fires
-
Lula, Bolsonaro in final debate showdown before Brazil vote
-
Hundreds of Syrians protest repeated Israeli incursions
US Justice Dept taking abortion pill fight to Supreme Court
The US Justice Department said Thursday that it will go to the Supreme Court to appeal restrictions imposed on a widely-used abortion pill in the latest round of an intensifying battle over reproductive rights.
The decision by President Joe Biden's administration came just hours after an appeals court rejected moves to ban mifepristone outright, but imposed a series of measures restricting access to the pill.
Mifepristone, which was approved by the Food and Drug Administration (FDA) in 2000 and accounts for more than half the abortions in the United States, has become the centerpiece of the country's latest clash over women's reproductive freedom.
Attorney General Merrick Garland said the Justice Department will be "seeking emergency relief from the Supreme Court to defend the FDA's scientific judgment and protect Americans' access to safe and effective reproductive care."
Speaking to reporters during Biden's visit to Dublin, Ireland, White House Press Secretary Karine Jean-Pierre said "we believe that the law is on our side, and we will prevail."
Late Wednesday, the US Fifth Circuit Court of Appeals said mifepristone, also known as RU 486, should remain available pending a full hearing of the case, but limited access to the first seven weeks of pregnancy, down from 10.
The appeals court also said in-person visits would be necessary to obtain the pill -- a requirement lifted in recent years -- and blocked the medication from being sent by mail.
The 2-1 ruling by the conservative-majority appeals court in New Orleans, Louisiana, came after a US District Court judge in Texas overturned the FDA's two-decades old approval of the drug last Friday.
- 'Furious' -
The appeals court said anti-abortion opponents had waited too long to challenge the drug's approval by the FDA but the judges' decision to impose restrictions on its use was denounced by groups seeking to maintain access to abortion.
"We are furious that yet another court would choose to jeopardize the health and futures of the millions of people who rely on mifepristone for abortion care," said Planned Parenthood president Alexis McGill Johnson.
Jennifer Dalven, director of the ACLU Reproductive Freedom Project, said "unless the Supreme Court steps in, this decision will prevent many people from getting abortion care and force them to remain pregnant against their will."
The anti-abortion group Susan B. Anthony described the appeals court ruling by two judges appointed by former Republican president Donald Trump as a "win."
"The court recognized that the abortion pill is dangerous and rolled back Biden's reckless mail-order abortion scheme," said Susan B. Anthony state policy director Katie Daniel. "We look forward to the Supreme Court hearing this case."
The latest standoff over abortion rights comes nearly a year after the Supreme Court, where conservatives wield a 6-3 majority, overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.
Mifepristone is one component of a two-drug regimen that can be used in the United States through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
- 'Unborn human' -
Last week's ruling by Judge Matthew Kacsmaryk, also a Trump appointee, seeking to impose a nationwide ban on mifepristone came in response to a suit by a coalition of anti-abortion groups.
The judge, in his decision, adopted language used by abortion opponents, saying the drug was used to "kill the unborn human."
Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.
The Biden administration and leading pharmaceutical and biotech companies also argued that Kacsmaryk's ruling risked undermining the entire drug approval authority of the FDA.
"If this decision stands, no medication -- from chemotherapy drugs, to asthma medicine, to blood pressure pills, to insulin -- would be safe from attacks," said Vice President Kamala Harris.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access to the procedure -- or ban it outright.
M.AlAhmad--SF-PST